Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback